Page 9 - Shenzhen Institutes Of Advanced Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shenzhen institutes of advanced technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shenzhen Institutes Of Advanced Technology Today - Breaking & Trending Today

Researchers develop deep learning model to predict occult peritoneal metastasis in gastric cancer patients

Researchers develop deep learning model to predict occult peritoneal metastasis in gastric cancer patients
Stomach cancer, or gastric cancer, is a common gastrointestinal malignancy. Peritoneal metastasis occurs in a majority of patients with advanced stomach cancer and is considered as an aggressive disease with poor outcomes.
Patients with peritoneal metastasis are typically not eligible for curative surgery. Therefore, preoperative detection and diagnosis of peritoneal metastasis are critical to inform treatment decision-making and avoid unnecessary surgery.
Related Stories
A new study published in the
JAMA Network Open on Jan. 5 shows that deep learning can help predicting the occult peritoneal metastasis in stomach cancer. It provides a novel and noninvasive approach for stomach cancer patients and may inform individualized surgical management of stomach cancer. ....

Liang Xiaokun , Emily Henderson , Peritoneal Metastasis Network Pmetnet , Network Open On Jan , Stanford University , Shenzhen Institutes Of Advanced Technology , Chinese Academy Of Sciences , Sun Yat Sen University Cancer Center , Shenzhen Institutes , Advanced Technology , Chinese Academy , Nanfang Hospital , Sun Yat Sen University Cancer , Peritoneal Metastasis Network , Co First Author , எமிலி ஹென்டர்சன் , வலைப்பின்னல் திறந்த ஆன் ஜான் , ஸ்டான்போர்ட் பல்கலைக்கழகம் , சீன கலைக்கழகம் ஆஃப் அறிவியல் , சூரியன் யத் சென் பல்கலைக்கழகம் புற்றுநோய் மையம் , ஷென்சென் நிறுவனங்கள் , சீன கலைக்கழகம் , சூரியன் யத் சென் பல்கலைக்கழகம் புற்றுநோய் , இணை முதல் நூலாசிரியர் ,

Chemotherapy drug outperforms remdesivir in inhibiting COVID-19

Chemotherapy drug outperforms remdesivir in inhibiting COVID-19
A study suggests that chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19
PTI | January 3, 2021 | Updated 16:40 IST
Represetational image (Photo- Reuters)
A chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19, according to a study based on computer simulations and lab experiments. The research, published in the journal PLOS Computational Biology, combined multiple computational techniques that simulate drug-virus interactions from different, complimentary perspectives.
Using this hybrid approach, scientists from the Shenzhen Institutes of Advanced Technology in China, screened 1,906 existing drugs for their potential ability to inhibit replication of the coronavirus by targeti ....

Haiping Zhang , Shenzhen Institutes Of Advanced Technology , Shenzhen Institutes , Advanced Technology , Covid 19 , Chemotherapy Medication , Chemotherapy Medicine For Covid 19 , ஷென்சென் நிறுவனங்கள் , கீமோதெரபி மருந்து ,

Chemotherapy drug outperforms remdesivir against coronavirus in lab experiments: Study

Chemotherapy drug outperforms remdesivir against coronavirus in lab experiments: Study
Beijing, Jan 3: A chemotherapy medication originally developed to treat cancer could potentially be repurposed to inhibit the replication of the novel coronavirus and treat COVID-19, according to a study based on computer simulations and lab experiments.
The research, published in the journal PLOS Computational Biology, combined multiple computational techniques that simulate drug-virus interactions from different, complimentary perspectives.
Using this hybrid approach, scientists from the Shenzhen Institutes of Advanced Technology in China, screened 1,906 existing drugs for their potential ability to inhibit replication of the coronavirus by targeting a viral protein called RNA-dependent RNA polymerase (RdRP). ....

Haiping Zhang , Shenzhen Institutes Of Advanced Technology , Shenzhen Institutes , Advanced Technology , ஷென்சென் நிறுவனங்கள் ,

Lymphoma drug outperforms Remdesivir against COVID-19 virus; read details

Lymphoma drug outperforms Remdesivir against COVID-19 virus; read details
orissapost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orissapost.com Daily Mail and Mail on Sunday newspapers.

Haiping Zhang , Shenzhen Institutes Of Advanced Technology , Shenzhen Institutes , Advanced Technology , ஷென்சென் நிறுவனங்கள் ,

Chemotherapy for lymphoma holds potential for Covid-19 treatment, study finds

A chemotherapy medication, originally developed to treat lymphoma, could potentially be repurposed to treat Covid-19, according to a study conducted by Haiping Zhang from the Shenzhen Institutes of Ad ....

Oxford Astrazeneca , Haiping Zhang , Shenzhen Institutes Of Advanced Technology , Shenzhen Institutes , Advanced Technology , Corona Virus , Covid 19 , ஷென்சென் நிறுவனங்கள் , கொரோனா வைரஸ் , சர்வதேச பரவல் ,